As a leading global life sciences company, AXBIO is dedicated to providing accessible multi-omics research solutions for life sciences and clinical medicine using cutting-edge semiconductor technology.
Established in Silicon Valley in 2016, AXBIO specializes in Bio-CMOS chips. Leveraging this technology, we have developed fourth-generation nanopore sequencers, multiplex nucleic acid analysis systems. Our nanopore sequencers utilize advanced electrochemical sensing, biochemical, and chemical synthesis technologies to overcome current sequencing limitations, offering cost-effective, long reads, high accuracy, high throughput, and real-time sequencing, which meet diverse research and clinical application needs across various fields and scenarios.
-
12 inchesNanopore sequencing wafer in mass-production
-
50+Global Patent Authorization/ Global patents granted
-
＞70%Percentage of R&D staff/ Proportion of R&D personnel
-
4100㎡+GMP Production Center
-
MissionDiscover the source code of life, safeguard the well-being of all -
VisionTo be a pioneer in building the foundational platforms of life sciences -
ValuesHonesty and Integrity, Result Oriented, Continuous Innovation, Resilient accountability, Teamwork
- PhD & MS, Stanford University; MS & BS, Tsinghua University, China
- Former VP of Roche Sequencing Unit
- VP at Genia, VP at Invisage, and Design Director at Pixim
- >50 granted US patents
- Responsible for the development of high-throughput sequencing chips for Roche and Genia
- Responsible for Invisage's quantum-dot image sensor chip (acquired by Apple) and Pixim's various image sensor products (acquired by Sony)
- PhD & MS, Saint Petersburg University, Russia
- Former VP of R&D at Invisage; VP at Intermolecular Technology
- Founder, CEO and CTO of Blue29; Founder of CuTek
- Technical Director at Mattson Technology; Technical Director at AMD
- >50 granted US patents and >50 peer-reviewed academic papers
- Responsible for Invisage's quantum-dot process development and production, Blue29’s superalloy nanomaterials and processes (acquired by KLA Tencor), CuTek's electroplating equipment (acquired by Mattson), and Intermolecular’s material development (listed on NASDAQ)
3350 Scott Blvd # B-9, Santa Clara, CA 95054, U.S.A.
info@axbio.co
+1-408-642-1287
